|
Market Closed -
TEL AVIV STOCK EXCHANGE
11:44:52 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1,020.00 ILa | 0.00% |
|
-0.58% | -6.76% |
| Market Cap | 116M 0 37.04M 33.17M 30.51M 27.65M 51.68M 3.52B 52.65M 364M 146M 1.85B 139M 136M 5.83B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 244M 0 77.77M 69.65M 64.06M 58.05M 109M 7.38B 111M 764M 307M 3.88B 292M 286M 12.25B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -0.58% | ||
| Current month | -8.85% | ||
| 1 month | -8.85% | ||
| 3 months | -7.94% | ||
| 6 months | -11.30% | ||
| Current year | -6.76% |
| 1 week | 1,012 |  | 1,050 |
| 1 month | 1,012 | | 1,209 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,679 |
| 5 years | 1,006 | | 2,566 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 23/08/1993 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 31/10/2018 |
| President | 80 | 27/06/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 24/06/2010 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 14/04/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.58% | -13.04% | -38.18% | 37.43M | |
| +3.00% | +11.21% | +67.70% | +150.35% | 1,224B | |
| -0.42% | +4.04% | +45.19% | +86.68% | 662B | |
| +1.13% | +2.96% | +28.88% | +107.27% | 514B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 388B | |
| +2.22% | +3.04% | +73.48% | +45.77% | 361B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 302B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 271B | |
| +1.10% | +6.15% | +59.68% | +77.16% | 249B | |
| +3.37% | +9.56% | +44.33% | +119.81% | 205B | |
| Average | +1.94% | +2.20% | +40.69% | +71.07% | 417.69B | |
| Weighted average by Cap. | +1.99% | +3.04% | +50.96% | +98.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 102M 91.66M 84.32M 76.4M 143M 9.72B 145M 1.01B 404M 5.11B 384M 376M 16.12B | 301M 0 95.76M 85.76M 78.88M 71.48M 134M 9.09B 136M 941M 378M 4.78B 359M 352M 15.08B |
| Net income | 6.21M 0 1.97M 1.77M 1.63M 1.47M 2.75M 187M 2.81M 19.4M 7.79M 98.61M 7.41M 7.25M 311M | -18.07M -0 -5.75M -5.15M -4.74M -4.29M -8.02M -546M -8.17M -56.49M -22.68M -287M -21.58M -21.12M -906M |
| Net Debt | 127M 0 40.43M 36.21M 33.31M 30.18M 56.41M 3.84B 57.47M 397M 159M 2.02B 152M 149M 6.37B | 128M 0 40.73M 36.47M 33.55M 30.4M 56.82M 3.87B 57.89M 400M 161M 2.03B 153M 150M 6.41B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | ILA 1,020.00 | 0.00% | 10 |
| 29/10/26 | ILA 1,020.00 | 0.00% | 758 |
| 28/10/26 | ILA 1,020.00 | 0.00% | 10 |
| 26/10/26 | ILA 1,020.00 | -0.58% | 1,100 |
| 23/10/26 | ILA 1,026.00 | -0.77% | 2,831 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
